Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-01 Tax Withholding | 2022-12-02 8:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer | 1,459 | $7.75 | 69,099 (Direct) | View |
| 2022-09-02 Option Award | 2022-09-06 7:08 pm | N/A 2032-09-02 | Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director | 29,482 | $0 | 29,482 (Direct) | View |
| 2022-09-02 Ownership | 2022-09-06 5:45 pm | N/A N/A | Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director | 0 | $0 | 1,232 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-02 5:00 pm | N/A N/A | Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer | 67,500 | $0 | 69,015 (Direct) | View |
| 2022-02-11 Option Award | 2022-02-15 4:01 pm | N/A 2032-02-11 | Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer | 185,000 | $0 | 185,000 (Direct) | View |
| 2021-06-07 Option Award | 2021-06-08 8:32 pm | N/A 2031-06-07 | Kinnate Biopharma Inc. | KNTE | Krishnamohan Neha Chief Financial Officer | 270,000 | $0 | 270,000 (Direct) | View |